← FDA Drug Approvals (Drugs@FDA)
DEXAMETHASONE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: COREPHARMA · Approved 2024-09-17
Drug application
- FDA Application #
ANDA218372
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DEXAMETHASONE
- Generic name
- DEXAMETHASONE
- Active ingredients
- DEXAMETHASONE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- COREPHARMA
- Manufacturer
- Advagen Pharma Ltd.
- First approval
- 2024-09-17
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown